Representation of the closed-loop device, the Control-IQ artificial pancreas system, which uses a control algorithm developed at the University of Virginia. (Courtesy: Tandem Diabetes Care) The burden ...
The FDA approved its first automatic insulin dosing system designed to deliver correction boluses as well as adjust background insulin levels to help prevent bouts of high and low blood sugar in ...
Currently, one closed-loop system, the Medtronic MiniMed 670G, is in commercial use in the United States, but randomized trials are needed to assess its efficacy and safety. 8 Such a system, which ...
In patients with diabetes, hospitalization can complicate the achievement of recommended glycemic targets. There is increasing evidence that a closed-loop delivery system (artificial pancreas) can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results